Mutations and prognosis in primary myelofibrosis
By A. Vannucchi, T. Lasho, P. Guglielmelli, F. Biamonte, A. Pardanani, Arturo Pereira, C. Finke, J. Score, N. Gangat, C. Mannarelli and 22 more. Leukemia, 2013
760 citations recorded by the source corpus.
Subfields: Genetics, Hematology, Rheumatology
View Paper: https://www.semanticscholar.org/paper/f430c075b30d95305aa44f79bcc5090390d7c3ce
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Hematology
Citations in the corpus
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. (2017, background): “Similarly, mutations in ASXL1, EZH2, and SRSF2 genes have been shown to identify patients with primary myelofibrosis who are at risk for leukemic transformation and who have particularly poor outcomes.(82,125) In contrast, NPM1 mutations, and CBF and KMT2A rearrangements are highly specific for de n”